Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles

INTRODUCTION: The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with Suprefact in IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) cycles. MATERIAL AND METHODS: In this randomized clinical trial performed in Royan Institute, 126...

Descripción completa

Detalles Bibliográficos
Autores principales: Tehraninejad, Ensieh Sh., Nekoo, Elham Azimi, Ezabadi, Zahra, Rashidi, Batool H., Amirchaghmaghi, Elham, Matroud, Elham Pour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2010
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302709/
https://www.ncbi.nlm.nih.gov/pubmed/22427771
http://dx.doi.org/10.5114/aoms.2010.19306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302709/
https://www.ncbi.nlm.nih.gov/pubmed/22427771
http://dx.doi.org/10.5114/aoms.2010.19306

Ejemplares similares